Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Marcel·lí Carbó"'
Autor:
Raúl López-Arnau, Jordi Camarasa, Marcel·lí Carbó, Núria Nadal-Gratacós, Pol Puigseslloses, María Espinosa-Velasco, Edurne Urquizu, Elena Escubedo, David Pubill
Publikováno v:
Frontiers in Psychiatry, Vol 13 (2022)
The utility of classical drugs used to treat psychiatric disorders (e.g., antidepressants, anxiolytics) is often limited by issues of lack of efficacy, delayed onset of action or side effects. Psychoactive substances have a long history of being used
Externí odkaz:
https://doaj.org/article/c04dc2a8c37c4056a65d6374717df04f
Autor:
Christian Griñán-Ferré, Marcel·lí Carbó, Manuel Vázquez-Carrera, Dolors Puigoriol-Illamola, Mercè Pallàs, Marta Alegret, Núria Roglans
Publikováno v:
EDULEARN Proceedings.
Autor:
Ricardo Pardo-Lozano, Magí Farré, Samanta Yubero-Lahoz, Brian O'Mathúna, Marta Torrens, Cristina Mustata, Clara Pérez-Mañá, Klaus Langohr, Elisabet Cuyàs, Marcel lí Carbó, Rafael de la Torre
Publikováno v:
PLoS ONE, Vol 7, Iss 10, p e47599 (2012)
The synthetic psychostimulant MDMA (± 3,4-methylenedioxymethamphetamine, ecstasy) acts as an indirect serotonin, dopamine, and norepinephrine agonist and as a mechanism-based inhibitor of the cytochrome P-450 2D6 (CYP2D6). It has been suggested that
Externí odkaz:
https://doaj.org/article/bace9d6b7b7444f5a3c29cf7e11c0bea
Autor:
Eulàlia Olesti, Toma, Ilario De, Ramaekers, Johannes G, Brunt, Tibor M, Marcel·Lí Carbó, Fernández-Avilés, Cristina, Robledo, Patricia, Magí Farré, Dierssen, Mara, Pozo, Óscar J, Torre, Rafael De La
Supplemental material, JOP812103_supplemental_material for Metabolomics predicts the pharmacological profile of new psychoactive substances by Eulàlia Olesti, Ilario De Toma, Johannes G Ramaekers, Tibor M Brunt, Marcel·lí Carbó, Cristina Fernánd
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4a7c342fc4ddcbfffc851243ec603175
Autor:
Anna Solans, Iñaki Izquierdo, Manel J. Barbanoj, Teresa Nadal, Esther Donado, Marcel-lí Carbó, Manuel Merlos, Juana Peña, Rosa M. Antonijoan
Publikováno v:
Clinical Therapeutics. 30:1639-1650
Background: Rupatadine is an oral active antihistamine and platelet-activating factor antagonist indicated for the management of allergic rhinitis and chronic urticaria in Europe. Objective: The purpose of this study was to describe the effect of the
Autor:
Irene Mazzoni, Olivier Rabin, Thierry Boghosian, Marcel-lí Carbó Banús, Osquel Barroso, Danielle Goudreault, Christiane Ayotte
Publikováno v:
Drug testing and analysis. 4(5)
Due to its stimulatory effects on the central nervous system, and its structural similarity to banned stimulants such as ephedrine and methamphetamine, pseudoephedrine (PSE) at high doses is considered as an ergogenic aid for boosting athletic perfor
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.